XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jan. 06, 2022
Jan. 06, 2022
Jan. 02, 2021
Jan. 02, 2017
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2019
Jan. 01, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock options outstanding         5,504,861     5,504,861   5,520,861    
Stock options outstanding weighted average exercise price         $ 1.84     $ 1.84   $ 1.84    
Stock options. intrinsic value         $ 0     $ 0        
Options to purchase shares               50,000        
Stock options exercise price               $ 1.21        
Stock options, weighted average remaining contractual term               5 years 11 months 1 day   6 years 3 months 25 days    
Warrant shares, outstanding         6,148,630     6,148,630   6,132,630    
Option exercise price                      
Employees [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation expense         $ 48,828     $ 99,370        
Unamortized stock option expense             $ 155,908   $ 155,908      
Non-Employees [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation expense         166,517     331,511        
Unamortized stock option expense         1,664,095     $ 1,664,095        
Weighted average period for unamortized stock compensation               2 years 7 months 2 days        
Share-Based Payment Arrangement, Option [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Options to purchase shares               50,000 546,000      
Stock options exercise price               $ 1.21 $ 5.60      
Share based compensation expense         215,535   722,966 $ 430,881 $ 1,068,941      
Share-Based Payment Arrangement, Option [Member] | Settlement of Accrued Compensation [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Options to purchase shares   50,000                    
Stock options exercise price   $ 1.21                    
Stock options, fair value   $ 68,614                    
Stock options, weighted average remaining contractual term   10 years                    
Share-Based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation expense         195,624   721,490 372,573 1,065,988      
Share-Based Payment Arrangement, Option [Member] | Research and Development Expense [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation expense         19,911   $ 1,476 58,308 2,953      
Equity Option [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Unamortized stock option expense         $ 1,820,003     $ 1,820,003        
2016 Plan [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of additional shares granted     569,826 564,378                
Number of shares available for grant       1,693,134 6,175,489     6,175,489   5,438,449   737,040
Number of shares for employee benefit               172,762     564,278  
Common Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of conversion of shares of notes and interest         31,983 43,666 839,724 75,649        
Warrant [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation expense         $ 20,433   $ 0 $ 20,433 $ 0      
Warrant shares, outstanding         6,148,630     6,148,630        
Class of warrant or right, outstanding, weighted average exercise price         $ 3.37     $ 3.37        
Class of warrant or right, outstanding, intrinsic value         $ 0     $ 0        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period   16,000                    
Warrants to purchase common stock 16,000 16,000                    
Options expiration period 5 years                      
Option exercise price   $ 1.25